Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Dingledine

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
ACS Chemical Neuroscience|April 24, 2020
An Agonist Dependent Allosteric Antagonist of Prostaglandin EP2 ReceptorsChunxiang Jiang, Radhika Amaradhi, Thota Ganesh, et al.
Advances in Experimental Medicine and Biology|July 12, 2014
When and how do seizures kill neurons, and is cell death relevant to epileptogenesis?Ray Dingledine, Nicholas H Varvel, F Edward Dudek
Brain, Behavior, & Immunity - Health|September 30, 2021
Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammationChunxiang Jiang, Aysegul Caskurlu, Thota Ganesh, et al.
ACS Medicinal Chemistry Letters|August 6, 2013
Discovery and characterization of carbamothioylacrylamides as EP<sub>2</sub> selective antagonistsThota Ganesh, Jianxiong Jiang, Rangaiah Shashidharamurthy, et al.
Journal of Medicinal Chemistry|April 30, 2014
Lead optimization studies of cinnamic amide EP2 antagonistsThota Ganesh, Jianxiong Jiang, Myung-Soon Yang, et al.
Annual Review of Pharmacology and Toxicology|September 18, 2025
Neuroinflammation and Disease: Pathways and OpportunitiesOlivia Hoffman, Nicholas H Varvel, Avtar S Roopra, et al.
Epilepsia|March 30, 2010
Region-specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoinBjørnar Hassel, Erik Taubøll, Renee Shaw, et al.
Scientific Reports|April 6, 2023
Pharmacological inhibition of the inflammatory receptor CCR2 relieves the early deleterious consequences of status epilepticusCarlos Alemán-Ruiz, Wenyi Wang, Ray Dingledine, et al.
Molecular Pharmaceutics|November 7, 2018
Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory PropertiesThota Ganesh, Avijit Banik, Ray Dingledine, et al.
Studies in Health Technology and Informatics|September 14, 2004
Text mining functional keywords associated with genesYing Liu, Martin Brandon, Shamkant Navathe, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
ACS Chemical Neuroscience|April 24, 2020
An Agonist Dependent Allosteric Antagonist of Prostaglandin EP2 ReceptorsChunxiang Jiang, Radhika Amaradhi, Thota Ganesh, et al.
Advances in Experimental Medicine and Biology|July 12, 2014
When and how do seizures kill neurons, and is cell death relevant to epileptogenesis?Ray Dingledine, Nicholas H Varvel, F Edward Dudek
Brain, Behavior, & Immunity - Health|September 30, 2021
Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammationChunxiang Jiang, Aysegul Caskurlu, Thota Ganesh, et al.
ACS Medicinal Chemistry Letters|August 6, 2013
Discovery and characterization of carbamothioylacrylamides as EP<sub>2</sub> selective antagonistsThota Ganesh, Jianxiong Jiang, Rangaiah Shashidharamurthy, et al.
Journal of Medicinal Chemistry|April 30, 2014
Lead optimization studies of cinnamic amide EP2 antagonistsThota Ganesh, Jianxiong Jiang, Myung-Soon Yang, et al.
Annual Review of Pharmacology and Toxicology|September 18, 2025
Neuroinflammation and Disease: Pathways and OpportunitiesOlivia Hoffman, Nicholas H Varvel, Avtar S Roopra, et al.
Epilepsia|March 30, 2010
Region-specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoinBjørnar Hassel, Erik Taubøll, Renee Shaw, et al.
Scientific Reports|April 6, 2023
Pharmacological inhibition of the inflammatory receptor CCR2 relieves the early deleterious consequences of status epilepticusCarlos Alemán-Ruiz, Wenyi Wang, Ray Dingledine, et al.
Molecular Pharmaceutics|November 7, 2018
Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory PropertiesThota Ganesh, Avijit Banik, Ray Dingledine, et al.
Studies in Health Technology and Informatics|September 14, 2004
Text mining functional keywords associated with genesYing Liu, Martin Brandon, Shamkant Navathe, et al.
Pageof 4